News & Updates

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed

25 Feb 2025 by

Neither SARS-CoV-2 infection exposure nor COVID-19 vaccination during pregnancy poses a significant risk to early child development, as shown in a population-level study said to be the largest to date.

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed

25 Feb 2025

Baloxavir shows promise in patients with nonsevere influenza

20 Feb 2025

In the treatment of patients with nonsevere influenza virus infection, baloxavir may reduce the risk of hospital admission and shorten the time to symptom relief, according to the results of a systematic review and meta-analysis.

Baloxavir shows promise in patients with nonsevere influenza

20 Feb 2025

Study supports early antiviral therapy in patients with moderate–high HBV viral load

19 Feb 2025

Early treatment with tenofovir alafenamide appears to lower the risk of serious liver-related adverse events in patients with noncirrhotic chronic hepatitis B virus (HBV) infection and moderate or high viraemia, regardless of alanine aminotransferase (ALT) concentrations, according to interim data from the ATTENTION trial conducted in South Korea.

Study supports early antiviral therapy in patients with moderate–high HBV viral load

19 Feb 2025

Antimicrobial stewardship helps reduce postelective caesarean antibiotic use

14 Feb 2025 by

An intervention with antimicrobial stewardship programs (ASPs) can prevent the unnecessary use of antibiotic prophylaxis in women following elective lower section caesarean section (eLSCS) with no adverse effects, according to a Singapore study.

Antimicrobial stewardship helps reduce postelective caesarean antibiotic use

14 Feb 2025

Cefiderocol safe to use in hospitalized children with bacterial infection

05 Feb 2025 by

A 3-hour infusion of cefiderocol in hospitalized paediatric patients is well tolerated and demonstrates activity against clinically relevant Gram-negative species of bacterial infections, reports a phase II study.

Cefiderocol safe to use in hospitalized children with bacterial infection

05 Feb 2025

$Oral noninferior to IV antibiotics for fracture-related infections$

Oral noninferior to IV antibiotics for fracture-related infections

04 Feb 2025

In the treatment of fracture-related infections, outcomes appear to be comparable when using oral vs intravenous (IV) antibiotics, according to a study.

Oral noninferior to IV antibiotics for fracture-related infections

04 Feb 2025

Age, high-risk conditions predict RSV hospitalization in children

04 Feb 2025

Hospitalization due to respiratory syncytial virus (RSV) infection in infants and children is significantly associated with younger age, high-risk conditions, and palivizumab-indicated underlying conditions, according to a study in Japan.

Age, high-risk conditions predict RSV hospitalization in children

04 Feb 2025

Experimental HPV vaccine shrinks high-grade precancerous cervical lesions

02 Feb 2025 by

A novel vaccine that targets HPV type 16 (HPV16) has shown clinical activity against HPV16-positive cervical intraepithelial neoplasia grade 3 (CIN3) in a phase II trial, substantially reducing lesion size.

Experimental HPV vaccine shrinks high-grade precancerous cervical lesions

02 Feb 2025

Which factors predict treatment initiation among individuals with negative TB result?

31 Jan 2025 by

Several factors, including male sex and reported cough, influence the decisions by clinicians to initiate tuberculosis (TB) treatment among individuals who receive a negative result on an initial bacteriological test for TB, reports a study.

Which factors predict treatment initiation among individuals with negative TB result?

31 Jan 2025

COVID-linked MIS-C outcomes reassuring at 6 months

31 Jan 2025 by

Children and young adults with multisystem inflammatory syndrome in children (MIS-C) related to COVID-19 infection show good cardiovascular and noncardiovascular outcomes at 6 months, according to data from the long-term MUSIC study.

COVID-linked MIS-C outcomes reassuring at 6 months

31 Jan 2025

News & Updates

Filter by Specialty:

Specialty:

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed

Baloxavir shows promise in patients with nonsevere influenza

Baloxavir shows promise in patients with nonsevere influenza

Study supports early antiviral therapy in patients with moderate–high HBV viral load

Study supports early antiviral therapy in patients with moderate–high HBV viral load

Antimicrobial stewardship helps reduce postelective caesarean antibiotic use

Antimicrobial stewardship helps reduce postelective caesarean antibiotic use

Cefiderocol safe to use in hospitalized children with bacterial infection

Cefiderocol safe to use in hospitalized children with bacterial infection

Oral noninferior to IV antibiotics for fracture-related infections

Oral noninferior to IV antibiotics for fracture-related infections

Age, high-risk conditions predict RSV hospitalization in children

Age, high-risk conditions predict RSV hospitalization in children

Experimental HPV vaccine shrinks high-grade precancerous cervical lesions

Experimental HPV vaccine shrinks high-grade precancerous cervical lesions

Which factors predict treatment initiation among individuals with negative TB result?

Which factors predict treatment initiation among individuals with negative TB result?

COVID-linked MIS-C outcomes reassuring at 6 months

COVID-linked MIS-C outcomes reassuring at 6 months